ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 156625 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 156625; 2) Community: the network communities that were significantly associated with the response to NSC 156625; 3) Molecule: the relationships between components within communities and NSC 156625; 4) MDR: the compounds that were significantly associated with the NSC 156625.

NSC Compound Enrichment Correlation
NSC 730944 3-bromo-4-(2-(4-methoxyphenyl)ethynyl)furan-2(5H)-one 0.0114553853234976 -0.12302049
NSC 747825 3-(4-fluorophenyl)-8,9-dimethyl-2-oxo-2,5-dihydropyrano[3,2-c]chromen-5-yl acetate 0.0114553853234976 -0.064917498
NSC 748643 Mitaplatin 0.0114553853234976 0.045929293
NSC 750040 Null 0.0114553853234976 -0.084889285
NSC 756413 GW876790X 0.0114553853234976 -0.12036404
NSC 129757 Null 0.0114553853234977 -0.15687093
NSC 251668 OVATIFOLIN ACETATE 0.0119653763676522 0.081273897
NSC 267461 Nanaomycin 0.0119653763676522 0.033730092
NSC 323241 3-Azabicyclo[3.2.2]nonane-3-carboselenoic acid, [1-(2-pyridinyl)ethylidene]hydrazide 0.0119653763676522 -0.038250619
NSC 338304 Iron, dichloro[hexahydro-1H-azepine-1-carbothioic acid [1-(2-pyridinyl)ethylidene]hydraziato] 0.0119653763676522 0.064074665
Total:71  Current:16    [First] [Prev] [Next] [Last]